QIMR Berghofer

Cross-ancestry genome-wide association study and systems-level integrative analyses implicate new risk genes and therapeutic targets for depression.

Abstract

Deciphering the genetic architecture of depression is pivotal for characterizing the associated pathophysiological processes and development of new therapeutics. Here we conducted a cross-ancestry genome-wide meta-analysis on depression (416,437 cases and 1,308,758 controls) and identified 287 risk loci, of which 49 are new. Variant-level fine mapping prioritized potential causal variants and functional genomic analysis identified variants that regulate the binding of transcription factors. We validated that 80% of the identified functional variants are regulatory variants, and expression quantitative trait loci analysis uncovered the potential target genes regulated by the prioritized risk variants. Gene-level analysis, including transcriptome and proteome-wide association studies, colocalization and Mendelian randomization-based analyses, prioritized potential causal genes and drug targets. Gene prioritization analyses highlighted likely causal genes, including TMEM106B, CTNND1, AREL...

Authors Li, Y; Dang, X; Chen, R; Teng, Z; Wang, J; Li, S; Yue, Y; Mitchell, BL; Zeng, Y; Yao, YG; Li, M; Liu, Z; Yuan, Y; Li, T; Zhang, Z; Luo, XJ
Journal NATURE HUMAN BEHAVIOUR
Pages
Volume
Date 24/03/2025
Grant ID U2102205 | National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund); 82301690 | National Natural Science Foundation of China (National Science Foundation of China)
Funding Body
URL http://www.ncbi.nlm.nih.gov/pubmed/?term=10.1038/s41562-024-02073-6